Klotho Neurosciences, Inc.
KLTO
$0.47
-$0.02-3.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.09M | -2.23M | -2.07M | -2.96M | -451.60K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.58M | 1.15M | 814.20K | 1.91M | 40.00K |
| Change in Net Operating Assets | -457.60K | -464.90K | 308.90K | -25.40K | -495.70K |
| Cash from Operations | -1.97M | -1.55M | -944.20K | -1.07M | -907.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | 28.90K | 2.12M | 1.20M | 150.00K | 950.00K |
| Total Debt Repaid | -2.73M | -- | -120.00K | -- | -- |
| Issuance of Common Stock | 11.89M | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 500.00K | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 140.60K | -65.20K | -120.00K | 128.50K | 770.40K |
| Cash from Financing | 9.83M | 2.06M | 957.00K | 278.50K | 1.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.87M | 502.10K | 12.80K | -794.40K | 813.00K |